Agilent Technologies (A) ROIC: History & Chart

Name: Agilent Technologies, Inc. (A) Return on Invested Capital (ROIC) — historical time series
Creator: TGMCharts

Compare

Agilent Technologies, Inc.(A)

Medical - Diagnostics & Research · Santa Clara, CA

$153.69+3.42 (+2.28%)

Delayed quote: Sep 16, 2026, 4:01 PM EDT

Compare

About Agilent Technologies, Inc.

Agilent Technologies, Inc. delivers specialized, application-focused technologies and services to the global life sciences, diagnostics, and applied chemistry industries. Its Life Sciences and Applied Markets segment provides a comprehensive portfolio of analytical instrumentation. This includes liquid chromatography (LC) and gas chromatography (GC) systems, often integrated with mass spectrometry (MS) for advanced analysis (LC-MS, GC-MS). They also offer inductively coupled plasma mass spectrometry (ICP-MS), atomic absorption (AA), microwave plasma-atomic emission spectrometry (MP-AES), and inductively coupled plasma optical emission spectrometry (ICP-OES) instruments, alongside Raman spectroscopy for material characterization. Beyond spectroscopy, the segment supplies cell analysis solutions such as plate-based assays, flow cytometers, real-time cell analyzers, imaging systems, and microplate readers. Complementing these are various laboratory software, information management platforms, data analytics tools, automated and robotic lab systems, dissolution testing equipment, vacuum technology, and general measurement solutions. The Diagnostics and Genomics division offers cutting-edge tools for genetic and diagnostic research. These encompass arrays designed for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression analysis. This segment also provides target enrichment solutions for next-generation sequencing, along with software for genetic data management and interpretation. Furthermore, it synthesizes custom oligonucleotides. Other significant offerings include immunohistochemistry (IHC), in situ hybridization (ISH), hematoxylin and eosin (H&E) staining, and specialized staining solutions. The division also supplies consumables and software essential for quality control analysis of nucleic acid samples, as well as reagents for turbidimetry and flow cytometry applications. A key area of development for this segment is liquid-based pharmacodiagnostics. Agilent CrossLab, the third segment, focuses on providing essential laboratory consumables and services. Its product range features GC and LC columns, products for sample preparation, custom chemical formulations, and various supplies for laboratory instruments. Complementary services include expert support for startup, ongoing operations, training, compliance, Software-as-a-Service (SaaS) offerings, asset management, and professional consultation. The company's products reach customers through a diverse sales network, including direct sales teams, distributors, resellers, manufacturer's representatives, and its e-commerce platforms. Agilent Technologies, Inc. was established in 1999 and maintains its corporate headquarters in Santa Clara, California.

Santa Clara, CA

18,100 employees

www.agilent.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Padraig McDonnell

View full financials

A Return on Invested Capital (ROIC) Metrics

RETURN ON INVESTED CAPITAL (ROIC)

11.88%

RETURN ON INVESTED CAPITAL (ROIC) AVG TTM

12.24%

RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y

12.54%

RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y

13.34%

RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y

11.25%

RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y

10.69%

RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y

9.81%

CURRENT VS TTM AVG

-2.94%

CURRENT VS 3Y AVG

-5.28%

CURRENT VS 5Y AVG

-10.95%

CURRENT VS 10Y AVG

+5.62%

CURRENT VS 15Y AVG

+11.10%

CURRENT VS 20Y AVG

+21.06%

SECTOR MEDIAN · HEALTHCARE

8.75%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

+35.85%

vs the sector median at left

NAME	MARKET CAP	RETURN ON INVESTED CAPITAL (ROIC)	TTM	3Y	5Y
Agilent Technologies, Inc. (A)	$43.41B	11.88%	12.24%	12.54%	13.34%
IQVIA Holdings Inc. (IQV)vs ›	$44.25B	8.32%	8.41%	8.23%	6.99%
Teva Pharmaceutical Industries Limited (TEVA)vs ›	$44.87B	6.79%	3.17%	0.33%	-0.73%
Humana Inc. (HUM)vs ›	$46.18B	4.52%	3.25%	5.37%	7.01%
IDEXX Laboratories, Inc. (IDXX)vs ›	$40.52B	41.33%	37.21%	35.10%	36.21%
Becton, Dickinson and Company (BDX)vs ›	$50.11B	3.72%	4.38%	4.32%	3.88%
Edwards Lifesciences Corporation (EW)vs ›	$51.41B	10.22%	11.08%	14.46%	15.87%
ResMed Inc. (RMD)vs ›	$33.11B	19.18%	19.41%	18.01%	17.23%
DexCom, Inc. (DXCM)vs ›	$32.96B	21.71%	13.47%	11.13%	9.67%
Centene Corp. (CNC)vs ›	$32.62B	-12.90%	-4.21%	-0.54%	0.75%

NAME

MARKET CAP

RETURN ON INVESTED CAPITAL (ROIC)

TTM

Agilent Technologies, Inc. (A)

$43.41B

11.88%

12.24%

12.54%

13.34%

IQVIA Holdings Inc. (IQV)vs ›

$44.25B

8.32%

8.41%

8.23%

6.99%

Teva Pharmaceutical Industries Limited (TEVA)vs ›

$44.87B

6.79%

3.17%

0.33%

-0.73%

Humana Inc. (HUM)vs ›

$46.18B

4.52%

3.25%

5.37%

7.01%

IDEXX Laboratories, Inc. (IDXX)vs ›

$40.52B

41.33%

37.21%

35.10%

36.21%

Becton, Dickinson and Company (BDX)vs ›

$50.11B

3.72%

4.38%

4.32%

3.88%

Edwards Lifesciences Corporation (EW)vs ›

$51.41B

10.22%

11.08%

14.46%

15.87%

ResMed Inc. (RMD)vs ›

$33.11B

19.18%

19.41%

18.01%

17.23%

DexCom, Inc. (DXCM)vs ›

$32.96B

21.71%

13.47%

11.13%

9.67%

Centene Corp. (CNC)vs ›

$32.62B

-12.90%

-4.21%

-0.54%

0.75%

Return on Invested Capital (ROIC) Formula & Definition

ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)

Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.

Return on Invested Capital (ROIC) FAQ

What is the return on invested capital (ROIC) for Agilent Technologies, Inc. (A)?

The return on invested capital (ROIC) for A stock is 11.88%.

Is Agilent Technologies, Inc.'s return on invested capital (ROIC) high or low?

The return on invested capital (ROIC) of 11.88% is 11% below its 5-year average of 13.34%, near the low end of its 5-year range (11.65%–15.61%).

What is the TTM average return on invested capital (ROIC) for Agilent Technologies, Inc. (A)?

The TTM average return on invested capital (ROIC) for A stock is 12.24%.

What is the 3Y average return on invested capital (ROIC) for Agilent Technologies, Inc. (A)?

The 3Y average return on invested capital (ROIC) for A stock is 12.54%.

What is the 5Y average return on invested capital (ROIC) for Agilent Technologies, Inc. (A)?

The 5Y average return on invested capital (ROIC) for A stock is 13.34%.

What is the 10Y average return on invested capital (ROIC) for Agilent Technologies, Inc. (A)?

The 10Y average return on invested capital (ROIC) for A stock is 11.25%.

What is the 15Y average return on invested capital (ROIC) for Agilent Technologies, Inc. (A)?

The 15Y average return on invested capital (ROIC) for A stock is 10.69%.

What is the 20Y average return on invested capital (ROIC) for Agilent Technologies, Inc. (A)?

The 20Y average return on invested capital (ROIC) for A stock is 9.81%.

DATE	RETURN ON INVESTED CAPITAL (ROIC)
2026-07-31	11.88%
2026-04-30	12.54%
2026-01-31	12.05%
2025-10-31	12.57%
2025-07-31	12.16%
2025-04-30	11.71%
2025-01-31	12.47%
2024-10-31	12.56%
2024-07-31	14.52%
2024-04-30	12.92%
2024-01-31	13.01%
2023-10-31	13.65%
2023-07-31	12.99%
2023-04-30	15.27%
2023-01-31	15.00%
2022-10-31	15.49%
2022-07-31	15.61%
2022-04-30	14.73%
2022-01-31	14.06%
2021-10-31	13.32%
2021-07-31	11.65%
2021-04-30	11.02%
2021-01-31	10.01%
2020-10-31	8.77%
2020-07-31	8.43%
2020-04-30	8.31%
2020-01-31	9.39%
2019-10-31	11.78%
2019-07-31	12.46%
2019-04-30	11.72%
2019-01-31	11.71%
2018-10-31	6.71%
2018-07-31	6.66%
2018-04-30	6.21%
2018-01-31	6.19%
2017-10-31	9.72%
2017-07-31	9.42%
2017-04-30	9.06%
2017-01-31	8.17%
2016-10-31	7.63%
2016-07-31	7.66%
2016-04-30	7.63%
2016-01-31	8.00%
2015-10-31	7.32%
2015-07-31	6.62%
2015-04-30	6.14%
2015-01-31	5.18%
2014-10-31	4.59%
2014-07-31	6.18%
2014-04-30	6.78%
2014-01-31	8.26%
2013-10-31	8.82%
2013-07-31	10.82%
2013-04-30	10.95%
2013-01-31	11.76%
2012-10-31	12.58%
2012-07-31	13.31%
2012-04-30	14.63%
2012-01-31	14.24%
2011-10-31	14.05%
2011-07-31	13.26%
2011-04-30	10.80%
2011-01-31	10.17%
2010-10-31	6.89%
2010-07-31	4.46%
2010-04-30	3.60%
2010-01-31	0.99%
2009-10-31	0.40%
2009-07-31	3.86%
2009-04-30	6.72%
2009-01-31	10.32%
2008-10-31	11.91%
2008-07-31	9.75%
2008-04-30	9.59%
2008-01-31	8.68%
2007-10-31	9.44%
2007-07-31	8.34%
2007-04-30	8.63%
2007-01-31	8.33%
2006-10-31	6.80%
2006-07-31	2.88%
2006-04-30	1.41%
2006-01-31	1.13%
2005-10-31	2.07%
2005-07-31	5.25%
2005-04-30	5.40%
2005-01-31	6.01%
2004-10-31	5.70%
2004-07-31	4.90%
2004-04-30	0.65%
2004-01-31	-8.41%
2003-10-31	-16.51%
2003-07-31	-27.80%

DATE

RETURN ON INVESTED CAPITAL (ROIC)

2026-07-31

11.88%

2026-04-30

12.54%

2026-01-31

12.05%

2025-10-31

12.57%

2025-07-31

12.16%

2025-04-30

11.71%

2025-01-31

12.47%

2024-10-31

12.56%

2024-07-31

14.52%

2024-04-30

12.92%

2024-01-31

13.01%

2023-10-31

13.65%

2023-07-31

12.99%

2023-04-30

15.27%

2023-01-31

15.00%

2022-10-31

15.49%

2022-07-31

15.61%

2022-04-30

14.73%

2022-01-31

14.06%

2021-10-31

13.32%

2021-07-31

11.65%

2021-04-30

11.02%

2021-01-31

10.01%

2020-10-31

8.77%

2020-07-31

8.43%

2020-04-30

8.31%

2020-01-31

9.39%

2019-10-31

11.78%

2019-07-31

12.46%

2019-04-30

11.72%

2019-01-31

11.71%

2018-10-31

6.71%

2018-07-31

6.66%

2018-04-30

6.21%

2018-01-31

6.19%

2017-10-31

9.72%

2017-07-31

9.42%

2017-04-30

9.06%

2017-01-31

8.17%

2016-10-31

7.63%

2016-07-31

7.66%

2016-04-30

7.63%

2016-01-31

8.00%

2015-10-31

7.32%

2015-07-31

6.62%

2015-04-30

6.14%

2015-01-31

5.18%

2014-10-31

4.59%

2014-07-31

6.18%

2014-04-30

6.78%

2014-01-31

8.26%

2013-10-31

8.82%

2013-07-31

10.82%

2013-04-30

10.95%

2013-01-31

11.76%

2012-10-31

12.58%

2012-07-31

13.31%

2012-04-30

14.63%

2012-01-31

14.24%

2011-10-31

14.05%

2011-07-31

13.26%

2011-04-30

10.80%

2011-01-31

10.17%

2010-10-31

6.89%

2010-07-31

4.46%

2010-04-30

3.60%

2010-01-31

0.99%

2009-10-31

0.40%

2009-07-31

3.86%

2009-04-30

6.72%

2009-01-31

10.32%

2008-10-31

11.91%

2008-07-31

9.75%

2008-04-30

9.59%

2008-01-31

8.68%

2007-10-31

9.44%

2007-07-31

8.34%

2007-04-30

8.63%

2007-01-31

8.33%

2006-10-31

6.80%

2006-07-31

2.88%

2006-04-30

1.41%

2006-01-31

1.13%

2005-10-31

2.07%

2005-07-31

5.25%

2005-04-30

5.40%

2005-01-31

6.01%

2004-10-31

5.70%

2004-07-31

4.90%

2004-04-30

0.65%

2004-01-31

-8.41%

2003-10-31

-16.51%

2003-07-31

-27.80%

Return on Invested Capital (ROIC): 11.88%

A Return on Invested Capital (ROIC)

A Average Return on Invested Capital (ROIC) Chart

A Current vs Average Return on Invested Capital (ROIC) Chart

A Return on Invested Capital (ROIC) Metrics

A Competitors' Return on Invested Capital (ROIC)

Capital Efficiency

Return on Invested Capital (ROIC) Formula & Definition

Return on Invested Capital (ROIC) FAQ

A Return on Invested Capital (ROIC) History

Related Metrics